| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.91B | 16.07B | 13.98B | 14.55B | 11.19B | 13.68B |
| Gross Profit | 10.71B | 16.07B | 14.45B | 14.50B | 11.14B | 13.63B |
| EBITDA | 2.04B | 0.00 | 3.05B | 2.76B | 179.00M | 1.97B |
| Net Income | 1.65B | 3.10B | 2.42B | 2.34B | 773.00M | 1.39B |
Balance Sheet | ||||||
| Total Assets | 69.12B | 73.16B | 63.48B | 74.03B | 61.56B | 64.51B |
| Cash, Cash Equivalents and Short-Term Investments | 29.31B | 25.99B | 24.79B | 29.84B | 25.78B | 23.35B |
| Total Debt | 4.80B | 2.75B | 3.26B | 4.34B | 5.28B | 4.29B |
| Total Liabilities | 30.14B | 30.83B | 23.38B | 31.21B | 22.54B | 25.44B |
| Stockholders Equity | 38.98B | 42.78B | 40.10B | 42.82B | 39.02B | 39.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.45B | -5.59B | 6.82B | -951.00M | -990.00M |
| Operating Cash Flow | 0.00 | 7.75B | -5.48B | 6.92B | -42.00M | -721.00M |
| Investing Cash Flow | 0.00 | -31.00M | 963.00M | 1.04B | -346.00M | -587.00M |
| Financing Cash Flow | 0.00 | -2.96B | -3.69B | -1.96B | -596.00M | -1.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥85.73B | 6.96 | ― | 5.75% | 30.59% | 55.29% | |
75 Outperform | ¥69.64B | 12.02 | 9.22% | 6.15% | 13.26% | 31.92% | |
68 Neutral | ¥38.37B | 18.08 | 7.66% | 5.47% | 12.83% | 32.86% | |
68 Neutral | ¥44.71B | 16.68 | ― | 4.36% | 3.23% | -11.76% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥233.66B | 13.77 | 14.00% | 5.13% | 34.33% | 47.34% | |
57 Neutral | ¥46.11B | 9.21 | ― | 4.86% | 10.70% | 63.03% |